| Name | Title | Contact Details |
|---|---|---|
Sherry Schnell |
Chief Compliance Officer and Associate General Counsel | Profile |
Malcolm Lloyd-Smith |
Chief Regulatory Officer | Profile |
Ingrid Delaet |
Chief Regulatory Officer | Profile |
David Bradfute |
Vice President and Head, Intellectual Property | Profile |
Darin Lippoldt |
Chief Legal Officer | Profile |
Chroma Medicine is pioneering a new class of epigenetic medicines to revolutionize treatment of genetically driven disease.
PharmaEssentia Corporation is a rapidly growing biopharmaceutical innovator. We are leveraging deep expertise and proven scientific principles to deliver effective new biologics for challenging diseases in the areas of hematology and oncology, with one product approved in The United States and a diversifying pipeline. We believe in the potential to improve both health and quality of life for patients with limited options today through the combination of rigorous research and innovative thinking.
Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins. The company is developing a wholly-owned pipeline of Centyrin-based therapeutic candidates and is working with industry partners to leverage Centyrins for tissue-specific targeting of therapeutics for a diverse set of diseases.
Ambient Eco Group is a Golden, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Folio Conversant is the premier provider of research services and biospecimen solutions. We offer an extensive array of quality biospecimens, particularly Human tissue and biofluids, supported by comprehensive laboratory and analytical services. Science does not stand still. Our goal is to become a key partner in supporting your team`s research and development in order to accelerate new diagnostic and therapeutic options for patients.